Atlas Trials

Study in Healthy Young Women to Investigate the Pharmacodynamics, Pharmacokinetics and Safety of Vilaprisan

Clinical trial NCT02262663 · COMPLETED

Trial details

NCT number
NCT02262663
Sponsor
Bayer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Clinical Trial, Phase I
Start date
2014-10-01
Primary completion
2015-09-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.